Cervical cancer drugs approved by the U.S. Food and Drug Administration include, Avastin (Bevacizumab), Bevacizumab, Bleomycin Sulfate, Hycamtin (Topotecan Hydrochloride), and Keytruda (Pembrolizumab) among others. The use of these drugs largely depends upon the stage and type of the cervical cancer being treated. Treatment by target therapy is a highly effective form of therapy that uses other substances or drugs to target and destroy specific cancer cells without affecting normal healthy cells nearby the tumor. Chemotherapy usually has a high success rate, especially when it is administered directly at the tumor site. Sometimes, additional treatment is required in order to achieve an acceptable rate of success. This additional treatment can take many forms, such as surgery, hormonal therapy, radiation therapy, stem cell transplantation, and combination therapy.
Cervical cancer drugs can be administered alone for in situ (stage 0) tumors. Stage of cancer means that it has spread to other parts of the cervix or to the lymph nodes and distant sites in the body. Stage 3 cancer is considered chronic; it has spread to the lymph nodes and distant sites in the body. The stage of cancer is very rarely found in women. A change in the form of a lump, wart or sore inside the cervix, bleeding or itching in the upper portion of the genitals and lower rectum, painful urination, lower back pain, fever, fatigue and weight loss are symptoms that a woman should be aware of.
Read More: http://bit.ly/38RQv0q